129-Epc1tm1e(EUCOMM)Wtsi/WtsiH
Status | Available to order |
EMMA ID | EM:04470 |
International strain name | 129-Epc1tm1e(EUCOMM)Wtsi/WtsiH |
Alternative name | EPD0002_3_G03 |
Strain type | Targeted Mutant Strains : Targeted Non-conditional |
Allele/Transgene symbol | Epc1tm1e(EUCOMM)Wtsi |
Gene/Transgene symbol | Epc1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0002_3_G03. For further details on the construction of this clone see the page at the IMPC portal. The targeted allele has lost the 3' loxP site. These mutations cannot be converted into conditional alleles. Click here for more information on EUCOMM final vectors. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- decreased leukocyte cell number / MGI
- abnormal muscle development / MGI
- decreased body weight / MGI
- increased mean corpuscular volume / MGI
- abnormal bone mineralization / MGI
- increased lactate dehydrogenase level / MGI
- abnormal behavior / MGI
- increased circulating creatine kinase level / MGI
- postnatal lethality, complete penetrance / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).